152 related articles for article (PubMed ID: 31348941)
1. A comparison of the effects of clozapine and its metabolite norclozapine on metabolic dysregulation in rodent models.
Yuen JWY; Wu C; Wang CK; Kim DD; Procyshyn RM; Honer WG; Barr AM
Neuropharmacology; 2020 Sep; 175():107717. PubMed ID: 31348941
[TBL] [Abstract][Full Text] [Related]
2. Effect of post-mortem changes on peripheral and central whole blood and tissue clozapine and norclozapine concentrations in the domestic pig (Sus scrofa).
Flanagan RJ; Amin A; Seinen W
Forensic Sci Int; 2003 Mar; 132(1):9-17. PubMed ID: 12689746
[TBL] [Abstract][Full Text] [Related]
3. CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.
Ozdemir V; Kalow W; Posner P; Collins EJ; Kennedy JL; Tang BK; Albers LJ; Reist C; Roy R; Walkes W; Afra P
J Clin Psychopharmacol; 2001 Aug; 21(4):398-407. PubMed ID: 11476124
[TBL] [Abstract][Full Text] [Related]
4. Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993-2007.
Couchman L; Morgan PE; Spencer EP; Flanagan RJ
Ther Drug Monit; 2010 Aug; 32(4):438-47. PubMed ID: 20463634
[TBL] [Abstract][Full Text] [Related]
5. Increasing the clozapine: norclozapine ratio with co-administration of fluvoxamine to enhance efficacy and minimize side effects of clozapine therapy.
Légaré N; Grégoire CA; De Benedictis L; Dumais A
Med Hypotheses; 2013 Jun; 80(6):689-91. PubMed ID: 23490199
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of the effects of the novel antipsychotic drug lurasidone on glucose tolerance and insulin resistance: a comparison with olanzapine.
Wu C; Yuen J; Boyda HN; Procyshyn RM; Wang CK; Asiri YI; Pang CC; Honer WG; Barr AM
PLoS One; 2014; 9(9):e107116. PubMed ID: 25254366
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic polypharmacy increases metabolic dysregulation in female rats.
Boyda HN; Procyshyn RM; Tse L; Xu J; Jin CH; Wong D; Pang CC; Honer WG; Barr AM
Exp Clin Psychopharmacol; 2013 Apr; 21(2):164-71. PubMed ID: 23356730
[TBL] [Abstract][Full Text] [Related]
8. A ganglionic blocker and adrenoceptor ligands modify clozapine-induced insulin resistance.
Yuen JWY; Wu C; Wang CK; Kim DD; Procyshyn RM; Panenka WG; Honer WG; Barr AM
Psychoneuroendocrinology; 2021 Jul; 129():105257. PubMed ID: 34023734
[TBL] [Abstract][Full Text] [Related]
9. Metabolic side-effects of the novel second-generation antipsychotic drugs asenapine and iloperidone: a comparison with olanzapine.
Boyda HN; Procyshyn RM; Pang CC; Hawkes E; Wong D; Jin CH; Honer WG; Barr AM
PLoS One; 2013; 8(1):e53459. PubMed ID: 23326434
[TBL] [Abstract][Full Text] [Related]
10. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.
Spina E; Avenoso A; Facciolà G; Scordo MG; Ancione M; Madia AG; Ventimiglia A; Perucca E
Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the metabolic side-effects of the second-generation antipsychotic drugs risperidone and paliperidone in animal models.
Boyda HN; Procyshyn RM; Tse L; Yuen JWY; Honer WG; Barr AM
PLoS One; 2021; 16(1):e0246211. PubMed ID: 33508013
[TBL] [Abstract][Full Text] [Related]
12. A parametric study of the acute effects of antipsychotic drugs on glucose sensitivity in an animal model.
Boyda HN; Tse L; Procyshyn RM; Wong D; Wu TK; Pang CC; Barr AM
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):945-54. PubMed ID: 20452386
[TBL] [Abstract][Full Text] [Related]
13. Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects.
Houseknecht KL; Robertson AS; Zavadoski W; Gibbs EM; Johnson DE; Rollema H
Neuropsychopharmacology; 2007 Feb; 32(2):289-97. PubMed ID: 17035934
[TBL] [Abstract][Full Text] [Related]
14. The clozapine to norclozapine ratio: a narrative review of the clinical utility to minimize metabolic risk and enhance clozapine efficacy.
Costa-Dookhan KA; Agarwal SM; Chintoh A; Tran VN; Stogios N; Ebdrup BH; Sockalingam S; Rajji TK; Remington GJ; Siskind D; Hahn MK
Expert Opin Drug Saf; 2020 Jan; 19(1):43-57. PubMed ID: 31770500
[No Abstract] [Full Text] [Related]
15. Semi-physiological Pharmacokinetic Model of Clozapine and Norclozapine in Healthy, Non-smoking Volunteers: The Impact of Race and Genetics.
Albitar O; Harun SN; Sheikh Ghadzi SM
CNS Drugs; 2024 Jul; 38(7):571-581. PubMed ID: 38836990
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model.
Chintoh AF; Mann SW; Lam L; Giacca A; Fletcher P; Nobrega J; Remington G
Schizophr Res; 2009 Mar; 108(1-3):127-33. PubMed ID: 19157785
[TBL] [Abstract][Full Text] [Related]
17. Clozapine: Dose, Sex, Ethnicity, Smoking Habit, Age, Body Weight, and Plasma Clozapine and N -Desmethylclozapine (Norclozapine) Concentrations in Clinical Practice.
Flanagan RJ; Hunter S; Obee SJ; Reeves S
J Clin Psychopharmacol; 2023 Mar-Apr 01; 43(2):131-138. PubMed ID: 36735578
[TBL] [Abstract][Full Text] [Related]
18. Associations between plasma clozapine/N-desmethylclozapine ratio, insulin resistance and cognitive performance in patients with co-morbid obesity and ultra-treatment resistant schizophrenia.
Costa-Dookhan KA; Rajji TK; Tran VN; Bowden S; Mueller DJ; Remington GJ; Agarwal SM; Hahn MK
Sci Rep; 2021 Jan; 11(1):2004. PubMed ID: 33479273
[TBL] [Abstract][Full Text] [Related]
19. Making sense of norclozapine levels: 3 clinical axioms.
Meyer JM
Schizophr Res; 2024 Jun; 268():289-292. PubMed ID: 37945386
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of clozapine and its primary metabolite norclozapine in Chinese patients with schizophrenia.
Li LJ; Shang DW; Li WB; Guo W; Wang XP; Ren YP; Li AN; Fu PX; Ji SM; Lu W; Wang CY
Acta Pharmacol Sin; 2012 Nov; 33(11):1409-16. PubMed ID: 22820910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
